The MedTech GTM Stress Test
Most Med-Tech launches don't fail because the technology is bad. They fail because of the space between a clinical success and a commercial machine.
This stress test, built on the Nexus Conflux Canvas, identifies where your launch is likely to leak cash. Grade yourself 1–5 on each statement below — where 5 means you are fully ready with an executable plan, and 1 means you have not started.
Low scores here result in delayed speed to revenue while figuring out how to turn the value of your product into a sale. This also leads to very high customer acquisition costs.
Low scores here lead to commercial stall. You have a clinically relevant product, but no revenue traction. Channel margins, reimbursement codes, or key influencers weren't aligned before the launch.
Low scores here cause burn rate explosion. Without clear leading indicators and support systems, you'll be forced to grow with expensive headcount, resulting in service failures that damage your brand's reputation just as you're trying to scale.
Scoring Key
40+ Points — Market Leader
You are ready for a full-scale launch. Strong commercial infrastructure with clear GTM alignment.
26–39 Points — High Risk
You have clinical momentum but commercial leakage. You likely need a Commercial Catalyst engagement to plug the gaps.
Below 25 Points — Critical Red Zone
Your launch is at risk of stalling in the first 6 months. A strategic facilitation workshop is recommended immediately.